Andhuvan G. A Study on Safety and Efficacy of Sodium-glucose Cotransporter-2 Inhibitors as Adjuvant to Insulin Add-on Therapy in Uncontrolled Type 2 Diabetic Patients. AJP [Internet]. 2018 Nov. 5 [cited 2024 Apr. 30];12(03). Available from: http://asiapharmaceutics.info/index.php/ajp/article/view/2625